Bio Wink

Active

Cooperative companyfounded 2019active for 7 yearsCongresstraat 35, 1000 Brussel, Belgium141 active companies are registered at this addressKBO/BCE: BE 0736.308.291

Summary

Bio Wink has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €38,779 and a net result of €11,659. Equity is growing by about 99% per year across the filed financial years. Its solvency ranks better than 40% of 6,153 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.7% (low).

Risk analysisFollow Report Compare

Bio WinkActiveChecked score 70/100

Risk analysis Report Compare

Activity

Wholesale of pharmaceutical and medical goods

NACE 46460

1 site

Size

≈ €220,000turnover 2025, estimated

Equity: €38,779
Profit: €11,659

Turnover estimated from the gross margin

Financial health

70 Healthy Checked score 2025

Bankruptcy probabilitywithin 12 months: 0.7%

Structure

2025 accounts 3 days early2 deeds in the Belgian Official Gazette

Why 70raises riskFounded in 2019Legal form: cooperative companyProfit of €11,659 (financial year 2025)lowers riskLiquidity: current ratio 1.57, cash €15,935, halvedShow the evidence

Checked score

Score 2025

70 / 100

Healthy

Probability in this band: 0.55% to 1.5%

Financially better than 60% of its sector peers (NACE 46, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Strong

Solvency 61+24

equity 36.4% of total assets

Liquidity 35-6

short-term debt 63.6% · cash 15.0%

Profitability 82-14

return on assets 10.9%

Bankruptcy probability, 12 months

0.7% Low

0%0.5%1.5%4%10%≥ 25%

About 7 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (26,896 companies, NACE 46, micro)

Last 24 months 11-2024: 2.8% 12-2024: 2.9%▲ +0.1 percentage points vs 11-2024highest value 01-2025: 2.8%▼ -0.1 percentage points vs 12-2024 02-2025: 0.9%▼ -1.9 percentage points vs 01-2025 03-2025: 0.9%● unchanged vs 02-2025 04-2025: 0.9%● unchanged vs 03-2025 05-2025: 0.9%● unchanged vs 04-2025 06-2025: 0.9%● unchanged vs 05-2025 07-2025: 0.9%● unchanged vs 06-2025 08-2025: 0.9%● unchanged vs 07-2025 09-2025: 0.9%● unchanged vs 08-2025 10-2025: 1.0%▲ +0.1 percentage points vs 09-2025 11-2025: 1.0%● unchanged vs 10-2025 12-2025: 0.9%▼ -0.1 percentage points vs 11-2025 01-2026: 0.9%● unchanged vs 12-2025 02-2026: 0.7%▼ -0.2 percentage points vs 01-2026 03-2026: 0.7%● unchanged vs 02-2026 04-2026: 0.7%● unchanged vs 03-2026 05-2026: 0.7%● unchanged vs 04-2026 06-2026: 0.7%● unchanged vs 05-2026 07-2026: 0.7%● unchanged vs 06-2026 08-2026: 0.6%▼ -0.1 percentage points vs 07-2026lowest value 09-2026: 0.6%● unchanged vs 08-2026lowest value 10-2026: 0.7%▲ +0.1 percentage points vs 09-2026

Credit of up to €2,500 on 30-day terms is acceptable

Liquidity ample (current ratio 1.57, compared with 1.13 in 2024, above the usual 1.5; short-term debt: 63.6% and cash: 15% of total assets), but 63.6% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, micro): better than 46% on solvency, 33% on liquidity, 76% on profitability and 85% on growth.

The bankruptcy probability was computed on 29-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskraises riskneutral

Founded in 2019

Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.

KBO

Liquidity: current ratio 1.57, cash €15,935, halved

NBB · annual accounts

Legal form: cooperative company

KBO

Profit of €11,659 (financial year 2025)

NBB · annual accounts

Latest accounts filed on time

The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 28-01-2026, 3 days ahead of the deadline.

NBB · 5 filings

Deviation from the deadline

2025

3 days early

2024

7 days early

2023

on the day

2022

21 days late

2021

40 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 5 accounts on average 6 days before the deadline; the sector median (NACE 46) for financial year 2024 is 3 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 28 January (4 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

30-06-2026 year end30-10-2026 today31-01-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

28-01-2026 Annual accounts filedfinancial year 2025 · full…
24-01-2025 Annual accounts filedfinancial year 2024 · full…
30-06-2024 Back to profitnet €48,576

Key points

Caution: Among the weakest 10% on equitysector median €1.6m · 6,085 companies €38,779 View
Total assets 20255 financial years filed €106,514 View
Active since 2019founded 11-10-2019 7 years View

By topic

Financials

Financial year: 2025
Total assets: €106,514
Profit: €11,659
Solvency: 36.4%

Total assets▼ 52.1%

Net result

20212025

Go to Financials

Timeline

Events: 7
Since: 2021
Next accounts: by 31-01-2027

31-01-2024Annual accounts filed
21-02-2023Annual accounts filed
30-06-2022Weakest financial year

Go to Timeline

Company details

Sites: 1

Legal form: Cooperative company
Activity: Wholesale of pharmaceutical and medical goodsNACE 46460
Founded: 11-10-2019
Year ends: 30-06
Peppol: Reachable for e-invoices

Go to Company details

Key facts about Bio Wink

What is the company number of Bio Wink?: 0736.308.291. In Belgium the VAT number is the company number with BE in front: BE 0736.308.291.
Where is Bio Wink based?: The registered office is at Congresstraat 35, 1000 Brussel.Company details
What does Bio Wink do?: According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of Bio Wink?: Cooperative company (CV).
When was Bio Wink founded?: On 11-10-2019.
Is Bio Wink still active?: Yes, Bio Wink is an active enterprise in the KBO register.
How many employees does Bio Wink have?: On average 1.2 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
What is the turnover of Bio Wink?: Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is Bio Wink profitable?: In financial year 2025, Bio Wink made a profit of €11,659.
Where can I find the annual accounts of Bio Wink?: Bio Wink filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Bio Wink due?: By 31-01-2027, for financial year 2026.Timeline